Cases & Deals

JumpStart invests in SironRX Therapeutics

Clients JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by SironRX Therapeutics, Inc., a start-up company developing an SDF-1 treatment to induce vascular and epithelial regeneration in sternotomy wounds.